You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
美单日新增25.5万宗新冠确诊 新增逾3,600宗死亡个案创新高
阿思达克 12-17 16:05
美国新冠疫情持续。据美国约翰霍普金斯大学统计,截至美国西岸时间午夜,即本港时间下午4时,美国累计新冠确诊16,979,777宗,单日新增255,024宗。累计新冠死亡个案307,501宗,单日新增3,652宗,为单日新高。

全球累计确诊人数逾7,424万人,累计死亡人数逾164万人。

美各州疫情方面,加州及德克萨斯州各录得171.49万宗及153.45万确诊,佛罗里达州录得115.53万宗确诊,伊利诺伊州及纽约州各录得87.06万及80.46万宗确诊,俄亥俄州及乔治亚州各录58.48万及56.06万宗,宾夕凡尼亚州录52.49万宗。

《今日美国报》报道,阿拉斯加健康护理员工接种辉瑞(PFE.US)新冠疫苗後出现严重过敏反应需要留医,目前已经康复。《CNBC》报道,纽约州州长科莫表示,若当地疫情未能受控,或於下月实施封城,停止所有非必要经济活动以遏止疫情,又指是否需要封城,关键在纽约市民於节假日的行为。

以下为过去八天美国每日新冠疫情统计,截数时间为美国西岸时间午夜。

日期│累计确诊│单日新增确诊│累计死亡│单日新增死亡

12月16日(三)│16,979,777宗│+255,024宗│307,501宗│+3,652宗**

12月15日(二)│16,724,753宗│+205,137宗│303,849宗│+3,370宗

12月14日(一)│16,519,616宗│+262,862宗**│300,479宗│+1,302宗

12月13日(日)│16,256,754宗│+189,723宗│299,177宗│+1,340宗

12月12日(六)│16,067,031宗│+216,017宗│297,837宗│+2,315宗

12月11日(五)│15,851,014宗│+234,633宗│295,522宗│+3,343宗

12月10日(四)│15,616,381宗│+224,681宗│292,179宗│+2,748宗

12月9日(三)│15,391,700宗│+220,024宗│289,431宗│+3,124宗

**纪录新高

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account